Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by product type
1.4.2. Market size breakdown, by analyte type
1.4.3. Market size breakdown, by application
1.4.4. Market size breakdown, by end user
1.4.5. Market size breakdown, by region
1.4.6. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Product Type (2017–2030)
7.2.1. Instrument-specific controls market revenue, by type (2017–2030)
7.3. Market Revenue, by Analyte Type (2017–2030)
7.4. Market Revenue, by Application (2017–2030)
7.5. Market Revenue, by End User (2017–2030)
7.6. Market Revenue, by Region (2017–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Product Type (2017–2030)
8.2.1. Instrument-specific controls market revenue, by type (2017–2030)
8.3. Market Revenue, by Analyte Type (2017–2030)
8.4. Market Revenue, by Application (2017–2030)
8.5. Market Revenue, by End User (2017–2030)
8.6. Market Revenue, by Country (2017–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Product Type (2017–2030)
9.2.1. Instrument-specific controls market revenue, by type (2017–2030)
9.3. Market Revenue, by Analyte Type (2017–2030)
9.4. Market Revenue, by Application (2017–2030)
9.5. Market Revenue, by End User (2017–2030)
9.6. Market Revenue, by Country (2017–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Product Type (2017–2030)
10.2.1. Instrument-specific controls market revenue, by type (2017–2030)
10.3. Market Revenue, by Analyte Type (2017–2030)
10.4. Market Revenue, by Application (2017–2030)
10.5. Market Revenue, by End User (2017–2030)
10.6. Market Revenue, by Country (2017–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Product Type (2017–2030)
11.2.1. Instrument-specific controls market revenue, by type (2017–2030)
11.3. Market Revenue, by Analyte Type (2017–2030)
11.4. Market Revenue, by Application (2017–2030)
11.5. Market Revenue, by End User (2017–2030)
11.6. Market Revenue, by Country (2017–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Product Type (2017–2030)
12.2.1. Instrument-specific controls market revenue, by type (2017–2030)
12.3. Market Revenue, by Analyte Type (2017–2030)
12.4. Market Revenue, by Application (2017–2030)
12.5. Market Revenue, by End User (2017–2030)
12.6. Market Revenue, by Country (2017–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Product Type (2017–2030)
13.2.1. Instrument-specific controls market revenue, by type (2017–2030)
13.3. Market Revenue, by Analyte Type (2017–2030)
13.4. Market Revenue, by Application (2017–2030)
13.5. Market Revenue, by End User (2017–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Product Type (2017–2030)
14.2.1. Instrument-specific controls market revenue, by type (2017–2030)
14.3. Market Revenue, by Analyte Type (2017–2030)
14.4. Market Revenue, by Application (2017–2030)
14.5. Market Revenue, by End User (2017–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Product Type (2017–2030)
15.2.1. Instrument-specific controls market revenue, by type (2017–2030)
15.3. Market Revenue, by Analyte Type (2017–2030)
15.4. Market Revenue, by Application (2017–2030)
15.5. Market Revenue, by End User (2017–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Product Type (2017–2030)
16.2.1. Instrument-specific controls market revenue, by type (2017–2030)
16.3. Market Revenue, by Analyte Type (2017–2030)
16.4. Market Revenue, by Application (2017–2030)
16.5. Market Revenue, by End User (2017–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Product Type (2017–2030)
17.2.1. Instrument-specific controls market revenue, by type (2017–2030)
17.3. Market Revenue, by Analyte Type (2017–2030)
17.4. Market Revenue, by Application (2017–2030)
17.5. Market Revenue, by End User (2017–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Product Type (2017–2030)
18.2.1. Instrument-specific controls market revenue, by type (2017–2030)
18.3. Market Revenue, by Analyte Type (2017–2030)
18.4. Market Revenue, by Application (2017–2030)
18.5. Market Revenue, by End User (2017–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Product Type (2017–2030)
19.2.1. Instrument-specific controls market revenue, by type (2017–2030)
19.3. Market Revenue, by Analyte Type (2017–2030)
19.4. Market Revenue, by Application (2017–2030)
19.5. Market Revenue, by End User (2017–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Product Type (2017–2030)
20.2.1. Instrument-specific controls market revenue, by type (2017–2030)
20.3. Market Revenue, by Analyte Type (2017–2030)
20.4. Market Revenue, by Application (2017–2030)
20.5. Market Revenue, by End User (2017–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Product Type (2017–2030)
21.2.1. Instrument-specific controls market revenue, by type (2017–2030)
21.3. Market Revenue, by Analyte Type (2017–2030)
21.4. Market Revenue, by Application (2017–2030)
21.5. Market Revenue, by End User (2017–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Product Type (2017–2030)
22.2.1. Instrument-specific controls market revenue, by type (2017–2030)
22.3. Market Revenue, by Analyte Type (2017–2030)
22.4. Market Revenue, by Application (2017–2030)
22.5. Market Revenue, by End User (2017–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Product Type (2017–2030)
23.2.1. Instrument-specific controls market revenue, by type (2017–2030)
23.3. Market Revenue, by Analyte Type (2017–2030)
23.4. Market Revenue, by Application (2017–2030)
23.5. Market Revenue, by End User (2017–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Product Type (2017–2030)
24.2.1. Instrument-specific controls market revenue, by type (2017–2030)
24.3. Market Revenue, by Analyte Type (2017–2030)
24.4. Market Revenue, by Application (2017–2030)
24.5. Market Revenue, by End User (2017–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Product Type (2017–2030)
25.2.1. Instrument-specific controls market revenue, by type (2017–2030)
25.3. Market Revenue, by Analyte Type (2017–2030)
25.4. Market Revenue, by Application (2017–2030)
25.5. Market Revenue, by End User (2017–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Product Type (2017–2030)
26.2.1. Instrument-specific controls market revenue, by type (2017–2030)
26.3. Market Revenue, by Analyte Type (2017–2030)
26.4. Market Revenue, by Application (2017–2030)
26.5. Market Revenue, by End User (2017–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Product Type (2017–2030)
27.2.1. Instrument-specific controls market revenue, by type (2017–2030)
27.3. Market Revenue, by Analyte Type (2017–2030)
27.4. Market Revenue, by Application (2017–2030)
27.5. Market Revenue, by End User (2017–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Product Type (2017–2030)
28.2.1. Instrument-specific controls market revenue, by type (2017–2030)
28.3. Market Revenue, by Analyte Type (2017–2030)
28.4. Market Revenue, by Application (2017–2030)
28.5. Market Revenue, by End User (2017–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Product Type (2017–2030)
29.2.1. Instrument-specific controls market revenue, by type (2017–2030)
29.3. Market Revenue, by Analyte Type (2017–2030)
29.4. Market Revenue, by Application (2017–2030)
29.5. Market Revenue, by End User (2017–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. LGC Limited
31.1.1. Business overview
31.1.2. Product and service offerings
31.2. Thermo Fisher Scientific Inc.
31.2.1. Business overview
31.2.2. Product and service offerings
31.2.3. Key financial summary
31.3. Bio-Rad Laboratories Inc.
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. F. Hoffmann-La Roche Ltd.
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. ZeptoMetrix LLC
31.5.1. Business overview
31.5.2. Product and service offerings
31.6. Quidel Corporation
31.6.1. Business overview
31.6.2. Product and service offerings
31.6.3. Key financial summary
31.7. Maine Molecular Quality Controls Inc.
31.7.1. Business overview
31.7.2. Product and service offerings
31.8. Microbiologics Inc.
31.8.1. Business overview
31.8.2. Product and service offerings
31.9. Bio-Techne Corporation
31.9.1. Business overview
31.9.2. Product and service offerings
31.9.3. Key financial summary
31.10. Qnostics Ltd.
31.10.1. Business overview
31.10.2. Product and service offerings
31.11. Fortress Diagnostics
31.11.1. Business overview
31.11.2. Product and service offerings
31.12. LGC Clinical Diagnostics Inc.
31.12.1. Business overview
31.12.2. Product and service offerings
31.13. Microbix Biosystems Inc.
31.13.1. Business overview
31.13.2. Product and service offerings
31.13.3. Key financial summary
31.14. bioMérieux SA
31.14.1. Business overview
31.14.2. Product and service offerings
31.14.3. Key financial summary
31.15. Anchor Molecular
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
LIST OF FIGURES
FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
FIG 2 RESEARCH METHODOLOGY
FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
FIG 6 DATA TRIANGULATION APPROACH
FIG 7 CURRENCY CONVERSION RATES FOR USD (2022)
FIG 8 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 THREAT OF NEW ENTRANTS
FIG 12 INTENSITY OF RIVALRY
FIG 13 THREAT OF SUBSTITUTES
FIG 14 GLOBAL MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
FIG 15 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 16 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 17 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 18 GLOBAL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 19 MAJOR WORLDWIDE MARKETS FOR MOLECULAR QUALITY CONTROLS, $M
FIG 20 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
FIG 21 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 22 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 23 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 24 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 25 NORTH AMERICA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)
FIG 26 EUROPE MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
FIG 27 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 28 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 29 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 30 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 31 EUROPE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)
FIG 32 APAC MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
FIG 33 APAC MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 34 APAC MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 35 APAC MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 36 APAC MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 37 APAC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)
FIG 38 LATAM MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
FIG 39 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 40 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 41 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 42 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 43 LATAM MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)
FIG 44 MEA MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT
FIG 45 MEA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 46 MEA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 47 MEA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 48 MEA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 49 MEA MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, $M (2017–2030)
FIG 50 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 51 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 52 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 53 U.S. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 54 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 55 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 56 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 57 CANADA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 58 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 59 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 60 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 61 GERMANY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 62 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 63 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 64 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 65 FRANCE MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 66 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 67 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 68 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 69 U.K. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 70 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 71 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 72 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 73 ITALY MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 74 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 75 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 76 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 77 SPAIN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 78 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 79 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 80 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 81 JAPAN MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 82 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 83 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 84 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 85 CHINA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 86 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 87 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 88 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 89 INDIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 90 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 91 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 92 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 93 AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 94 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 95 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 96 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 97 SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 98 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 99 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 100 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 101 BRAZIL MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 102 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 103 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 104 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 105 MEXICO MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 106 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 107 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 108 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 109 SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 110 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 111 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 112 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 113 SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 114 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT TYPE, $M (2017–2030)
FIG 115 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, $M (2017–2030)
FIG 116 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, $M (2017–2030)
FIG 117 U.A.E. MOLECULAR QUALITY CONTROLS MARKET, BY END USER, $M (2017–2030)
FIG 118 THERMO FISHER SCIENTIFIC INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 119 BIO-RAD LABORATORIES INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 120 F. HOFFMANN-LA ROCHE LTD. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 121 QUIDEL CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 122 BIO-TECHNE CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 123 MICROBIX BIOSYSTEMS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
FIG 124 BIOMÉRIEUX SA – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2022)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer